PCR analyzers for CLIA-waived respiratory PCR testing

The Indian Health Service seeks FDA-cleared and CLIA-waived respiratory PCR analyzers and associated testing consumables for four Oklahoma Area outpatient facilities, with quotations due October 2, 2026, at 10:00 AM CT. This is a one-year Blanket Purchase Agreement with a $340,000 aggregate ceiling; individual calls do not exceed $250,000.

Place of performance is Clinton, Oklahoma. The procurement is full and open competition with no set-asides. Equipment, delivery, installation, configuration, preventative maintenance, repairs, training, and technical support are provided at no cost to the Government; costs derive solely from CLIA-waived respiratory testing consumables (panels and quality control materials) purchased on a firm-fixed-price basis, with facility-level minimum quantity commitments.

The BioFire SPOTFIRE system is the brand-name reference product. Acceptable equal products must meet salient characteristics including PCR-based closed-cartridge methodology, 30-minute or less result time, touchscreen interface with barcode scanning, Data Innovations middleware compatibility, and scalable modular throughput with one to four testing modules per control unit. Contractor personnel must be manufacturer-trained and qualified, with credential verification and removal/replacement provisions for unqualified staff. The contractor must complete deployment within 60 calendar days of award and provide direct technical support during facility business hours (8:00 am to 4:30 pm Monday–Friday) with two-business-day maximum repair turnaround.

Evaluation emphasizes technical conformance with salient characteristics over price, with past performance considered as an indicator of ability to perform. Regulatory compliance includes Privacy Act, HIPAA, 42 CFR Part 2, and Section 508 accessibility standards. NAICS code 334516, PSC code 6640. Quotations submitted via email to maryann.yocham@ihs.gov.